Qiagen N.V. (BIT:1QGEN)
41.93
0.00 (0.00%)
At close: Oct 31, 2025
Qiagen Revenue
Qiagen had revenue of $533.54M USD in the quarter ending June 30, 2025, with 7.49% growth. This brings the company's revenue in the last twelve months to $2.04B, up 5.15% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.04B
Revenue Growth
+5.15%
P/S Ratio
5.07
Revenue / Employee
$378.07K
Employees
5,396
Market Cap
8.81B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| Amplifon | 2.41B |
| DiaSorin | 1.22B |
| Safilo Group | 998.89M |
| EL.En. | 579.71M |
| Svas Biosana | 134.95M |
| Pharmanutra | 122.25M |
| Philogen | 84.66M |